MAPT and Alzheimer disease: Activation of noncanonical Wnt signalling enhances Aβ production, while activation of canonical Wnt signalling suppresses Aβ production.166 Third, GSK3β is activated in the AD brain, and the hyperphosphorylation of tau protein in AD patients is mediated by GSK-3β.